High Point Advisor Group LLC Collegium Pharmaceutical, Inc Transaction History
High Point Advisor Group LLC
- $1.67 Billion
- Q3 2024
A detailed history of High Point Advisor Group LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 13,432 shares of COLL stock, worth $413,974. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,432
Previous 13,432
-0.0%
Holding current value
$413,974
Previous $432,000
20.14%
% of portfolio
0.03%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding COLL
# of Institutions
252Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...